Endpoints
Adherence was calculated as the percentage of the prescribed doses that were taken by the patient. For meglumine antimoniate this is expressed in terms of ampoules. The primary endpoint was the proportion of participants who were monitored at or around week 26, which is within the time range for the consensus definition of final cure [